Etretinate embryotoxicity 7 months after discontinuation of treatment.
Verloes
A
A
Dodinval
P
P
Koulischer
L
L
Lambotte
R
R
Bonnivert
J
J
D000014:Abnormalities, Drug-Induced; D000015:Abnormalities, Multiple / Q000139:chemically induced*; D005050:Etretinate / Q000009:adverse effects*; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D006801:Humans; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D005050:Etretinate